Eligibility Criteria

Inclusion and exclusion criteria
Description

Inclusion and exclusion criteria

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0680251
The study was based on formalin-fixed paraffin embedded (FFPE) primary tumor blocks from female patients diagnosed with estrogen receptor positive invasive breast cancer in the province of British Columbia in Canada between 1986 and 1992. Patients were treated with five years of adjuvant tamoxifen, no chemotherapy, and followed for breast cancer specific survival and relapse free survival.
Description

The study was based on formalin-fixed paraffin embedded (FFPE) primary tumor blocks from female patients diagnosed with estrogen receptor positive invasive breast cancer in the province of British Columbia in Canada between 1986 and 1992. Patients were treated with five years of adjuvant tamoxifen, no chemotherapy, and followed for breast cancer specific survival and relapse free survival.

Data type

boolean

Alias
UMLS CUI [1,1]
C4684951
UMLS CUI [1,2]
C0677930
UMLS CUI [1,3]
C2938924
UMLS CUI [1,4]
C0853879
UMLS CUI [1,5]
C0079946
UMLS CUI [1,6]
C0006193
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0872291
UMLS CUI [2,3]
C1522673
UMLS CUI [2,4]
C0039286
UMLS CUI [2,5]
C1298908
UMLS CUI [2,6]
C3665472
UMLS CUI [2,7]
C1522577
UMLS CUI [2,8]
C2986538
UMLS CUI [2,9]
C4551700

Similar models

Eligibility Criteria

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion and exclusion criteria
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
The study was based on formalin-fixed paraffin embedded (FFPE) primary tumor blocks from female patients diagnosed with estrogen receptor positive invasive breast cancer in the province of British Columbia in Canada between 1986 and 1992. Patients were treated with five years of adjuvant tamoxifen, no chemotherapy, and followed for breast cancer specific survival and relapse free survival.
Item
The study was based on formalin-fixed paraffin embedded (FFPE) primary tumor blocks from female patients diagnosed with estrogen receptor positive invasive breast cancer in the province of British Columbia in Canada between 1986 and 1992. Patients were treated with five years of adjuvant tamoxifen, no chemotherapy, and followed for breast cancer specific survival and relapse free survival.
boolean
C4684951 (UMLS CUI [1,1])
C0677930 (UMLS CUI [1,2])
C2938924 (UMLS CUI [1,3])
C0853879 (UMLS CUI [1,4])
C0079946 (UMLS CUI [1,5])
C0006193 (UMLS CUI [1,6])
C0087111 (UMLS CUI [2,1])
C0872291 (UMLS CUI [2,2])
C1522673 (UMLS CUI [2,3])
C0039286 (UMLS CUI [2,4])
C1298908 (UMLS CUI [2,5])
C3665472 (UMLS CUI [2,6])
C1522577 (UMLS CUI [2,7])
C2986538 (UMLS CUI [2,8])
C4551700 (UMLS CUI [2,9])